CD19-CAR-T in B-cell Malignancies Patients

NCT03952923 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

B-cell Malignancy

Interventions

BIOLOGICAL: CD19-CAR-T cells

Sponsor

Hebei Yanda Ludaopei Hospital

Collaborators

[object Object]
[object Object]